Evidence map›Paper›PMID 41295950›Full record

ArticleThe Journal of experimental medicine2026

A common progenitor gives rise to fibroblastic reticular cells and vascular smooth muscle cells in murine lymph nodes.

Lisa Kurz, Mechthild Lütge, Angelina De Martin, Hung-Wei Cheng, Elina Bugar, Yves Stanossek, Samuel Meili, Joshua D Brandstadter, Ivan Maillard, Lucas Onder and 1 more

Abstract read
In one paragraph

Article in The Journal of experimental medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Lisa Kurz *Institute of Immunobiology, Cantonal Hospital St. Gallen , St. Gallen, Switzerland.ORCID 0000-0002-0557-2636
Mechthild Lütge *Institute of Immunobiology, Cantonal Hospital St. Gallen , St. Gallen, Switzerland.ORCID 0000-0001-9011-5319
Angelina De MartinInstitute of Immunobiology, Cantonal Hospital St. Gallen , St. Gallen, Switzerland.ORCID 0000-0002-9056-8075
Hung-Wei ChengInstitute of Immunobiology, Cantonal Hospital St. Gallen , St. Gallen, Switzerland.ORCID 0000-0003-1740-0337
Elina BugarInstitute of Immunobiology, Cantonal Hospital St. Gallen , St. Gallen, Switzerland.ORCID 0009-0003-7837-2779
Yves StanossekInstitute of Immunobiology, Cantonal Hospital St. Gallen , St. Gallen, Switzerland.ORCID 0009-0005-5117-2384
Samuel MeiliInstitute of Immunobiology, Cantonal Hospital St. Gallen , St. Gallen, Switzerland.ORCID 0009-0009-0550-8851
Joshua D BrandstadterDivision of Hematology-Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.ORCID 0000-0003-0652-5791
Ivan MaillardDivision of Hematology-Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.ORCID 0000-0003-1312-6748
Lucas OnderInstitute of Immunobiology, Cantonal Hospital St. Gallen , St. Gallen, Switzerland.ORCID 0000-0003-1471-412X
Burkhard LudewigInstitute of Immunobiology, Cantonal Hospital St. Gallen , St. Gallen, Switzerland.ORCID 0000-0002-7685-573X

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
HEMATOLOGY CLINICAL RESEARCH TRAINING PROGRAMT32HL007439 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI LAWRENCE F BRASS, PETER S KLEIN · 1985 to 2026
$17.1M
Institutional Clinical and Translational Science AwardKL2TR001879 · NCATS · UNIVERSITY OF PENNSYLVANIA · PI MEAGHER, EMMA ANNE · 2016 to 2025
$13.7M
Notch Signaling in AlloimmunityR01AI091627 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI PEAR, WARREN S · 2011 to 2025
$6.0M
Notch ligands as oncogenic drivers and therapeutic targets in T-cell lymphomasR01CA278976 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Ivan Maillard, Ryan A Wilcox · 2024 to 2026
$1.9M
American Society of Hematology KL2-TR001879American Society of Hematology T32-HL007439American Society of Transplantation and Cellular TherapyNCATS NIH HHS KL2 TR001879NCI NIH HHS P30 CA008748NCI NIH HHS R01 CA278976NHLBI NIH HHS T32 HL007439NIAID NIH HHS R01 AI091627NIH HHS R01-AI091627NIH HHS R01-CA278976Research Commission of the Kantonsspital St. Gallen 19/07Swiss National Science Foundation 182583Swiss National Science Foundation 212260
6 · The paper itself

Abstract

The interaction of immune cells in the lymph node microenvironment depends on the infrastructure and molecular cues provided by fibroblastic reticular cells (FRCs). In addition, concentric layers of still poorly defined mural cells, including vascular smooth muscle cells (VSMCs), are involved in positioning and regulating immune cell interactions in different lymph node compartments. Using time-resolved single-cell transcriptomics, combined with cell fate mapping and high-resolution confocal microscopy, we found that lymph node FRCs and VSMCs share a proliferating, CCL19-expressing embryonic progenitor. Trajectory analysis identified lymphotoxin β receptor (LTβR)-dependent lineages that gave rise to FRCs underpinning the subcapsular sinus, T and B cell zones, and the medulla. LTβR-independent development of VSMCs and perivascular reticular cells from the common progenitor highlighted the close developmental relationship between FRCs and mural cells. Collectively, these results indicate that CCL19-expressing perivascular progenitors are capable of generating the fibroblastic and mural cell infrastructure of murine lymph nodes.

Indexed as

FibroblastsLymph NodesMuscle, Smooth, VascularMyocytes, Smooth MuscleStem CellsAnimalsCell DifferentiationCell LineageChemokine CCL19Lymphotoxin beta ReceptorMiceMice, Inbred C57BLChemokine CCL19Lymphotoxin beta Receptor

Identifiers

PMID41295950
PMCPMC12651234

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.